This tumor suppressor function results from the ubiquitination and degradation of insulin-like growth factor 1 receptor (IGF1R) promoted by AIRAPL and requires key players in ERAD, such as p97, FAF2 and BAG664. This evidence concerns the gene VCP and neoplasm.